Breaking News

Citius Pharmaceuticals to Accelerate Phase 3 Mino-Lok Trial by Expanding Trial Sites Internationally

Additional web sites to assist demo completion by end of 2022 CRANFORD, N.J. , Might 6, 2022 /PRNewswire/ — Citius Prescribed drugs, Inc. (“Citius” or the “Firm”) (Nasdaq: CTXR), a late-stage biopharmaceutical firm acquiring and commercializing first-in-course crucial care goods, these days declared that it has chosen Biorasi, LLC (“Biorasi”), a international scientific exploration group […]